VIICTR Profiles
ORIT
Pediatrics CRA
Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Dalcetrapib Reduces Risk of New-Onset Diabetes in Patients With Coronary Heart Disease.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Dalcetrapib Reduces Risk of New-Onset Diabetes in Patients With Coronary Heart Disease.
Dalcetrapib Reduces Risk of New-Onset Diabetes in Patients With Coronary Heart Disease. Diabetes Care. 2020 05; 43(5):1077-1084.
View in:
PubMed
subject areas
Acute Coronary Syndrome
Aged
Amides
Anticholesteremic Agents
Blood Glucose
Cohort Studies
Coronary Disease
Diabetes Mellitus, Type 2
Esters
Female
Humans
Incidence
Male
Middle Aged
Prediabetic State
Risk Factors
Risk Reduction Behavior
Sulfhydryl Compounds
authors with profiles
CHRISTIE BALLANTYNE